Content is loading...

Hide this page Language and accessibility
25 September 2026

Reusable tourniquets

Brittany Keefe, Quality Coordinator

The Infection Prevention and Control (IPAC) identified that tourniquets were a high volume item, causing unnecessary cost and waste. They wanted to address the environmental, financial, and clinical impact of single-use tourniquets to support more sustainable practice.

The aim was to support the NHS green plan so that we can help achieve net zero targets by reducing waste, carbon footprint, and costs through transitioning from a single-use tourniquet to reusable ones across our Legacy CCS services, which undertake blood collection.

Hello everyone. My name is Brittany Keefe.

I'm a quality coordinator for the support services, originally from the Legacy CCS Trust. The project was a sustainability project, a QI-focused project that we did for IPAC. It was on the reduction of single-use tourniquets within the NHS Community Services by looking at moving to reusable tourniquets.

Okay, next slide, please.

So the excessive use of single-use equipment in the NHS, which includes tourniquets, is contributing massively to plastic waste, carbon emissions, and higher costs. As you're aware, we have a green plan to work towards, and we need to help achieve the goal of net zero by 2050.

So to help this, we can use reusable alternatives, which will allow us to reduce waste, lower carbon footprint, and save money in areas.

But we must make sure that we're still considering the infection prevention control factors, as well as making sure that our patients stay safe. Next slide, please.

The next slide. Yeah, thank you. So there was a discussion at the IPAC Link Champions meeting back in March 2024, which identified that there was a need for change, sustainability wise.

Then in June 2025, we found that it was time to undertake a sustainability project and identified that there were tourniquets, which were a high volume item, causing unnecessary cost and waste. Our purpose was to address the environmental, financial, and clinical impact of single-use tourniquets to support more sustainable practice. Our aim was to support the NHS green plan so that we can help achieve net zero targets by reducing waste, carbon footprint, and costs through transitioning from a single-use tourniquet to reusable ones across our Legacy CCS services, which undertake blood collection.

But by doing this, we need to consider the IPAC standards and patient safety.

Next slide.

We researched the pros and cons to both the single use and the reusable tourniquets. As you can see there, there's pros and cons to both.

The single use is good because it saves time. They're very IPAC friendly.

However, they do create a lot of waste, and CO2 is higher from the long-term costs.

Whereas reusable ones, they significantly reduce waste and costs, but they do take more time due to cleaning, and there's currently no pediatric sizes at the moment available as well. However, the same level of IPAC can be achieved for reusable ones by wiping them down before and after use.

With time, this would become second nature. But obviously, what we want to do is reduce the waste, CO2, and costs. Next slide.

So what we did, after we researched, we found... Oh, I can hear myself.

We found the Daisy Grip reusable tourniquets.

So we contacted the Legacy CCS services, which undertook blood collection to see who'd volunteer to trial these tourniquets.

We had three services respond, iCaSH, Lime Tree, Milton Keynes as well, and Luton Adult Phlebotomy. We got in touch with Trisel, who are the manufacturer of Daisy Grip, for a trial and coordinated with the services to agree a start date.

We received an evaluation form from Trisel and transformed it into an MS Form where we could collect the feedback from the services.

Prior to the start of the trial, the Trisel representative carried out face-to-face training with the services and six tourniquets were also provided.

The trial commenced on Monday the 1st of December and concluded on the 31st of December '25. Next slide. Yeah. While the Daisy Grip trials were happening, we researched if there were any other reusable tourniquets on the market.

We found the Vacuette Easy Clean by Greiner.

Once we spoke to one of their representatives, we agreed a three-week trial for this one as well at the same site, starting on Monday the 9th of March, with two tourniquets provided per site. Once all the trials had finished, then we collated the feedback. Next slide.

So as you can see here, we received feedback from both staff and patients from all the sites on both tourniquets. The Daisy Grip was very mixed. It was a 50/50.

Unfortunately, the majority of the feedback for the Vacuette Easy Clean was negative. We believe that this was due to the possibility of staff just needing more time to practice with the tourniquets and persevere where it wasn't going so well for them as the patient. The clear winner here is Daisy Grip.

Maybe this is one that the services could consider moving to in the future.Next slide, yeah. Here you can see some feedback from the services themselves and from patients. So iCaSH, Lime Tree felt that the Daisy Grip was very easy to clean, whereas Milton Keynes found that they were quite heavy in comparison to others. And the phlebotomy team felt that the Vacuette Easy Clean ones were better than the other reusable ones that they've tried before.

iCaSH, Lime Tree  felt that they didn't go tight enough to reach full potential.

Next slide, yeah.

So here you can see that we did work out the waste, the CO2, and the costs for both the single use and reusable tourniquets per year.

Currently, Legacy CCS services are purchasing 35,050 tourniquets, so single use per year.

So it's costing us around 4,430, as well as disposable costs as a £95 added per year. Whereas the reusable ones, they only cost around 676 per year to purchase and then £75 within for waste, saving us a total of 3,774, which is 83% per year if we transition to two reusable. I think it's quite a lot.

And then you can also see the CO2 saved, which is about 10.9kgs, 21% of the equivalent of driving a petrol car for about 50 miles.

So not a massive reduction in CO2, but it is a difference which counts as being more sustainable.

Next slide.

So what went well and the challenges that we faced.

We did receive some positive feedback from the services, which showed us the preference for the Daisy Grip. As you saw there, there's a clear reduction in costs, waste, and carbon footprint, which can be achieved if we transition to the reusable tourniquets. However, the feedback received showed that there were challenges with the staff that were hesitant to use due to a resistance to change, which we believe was a need for additional training support to make this change.

The feedback that we collected was also limited due to service pressures, lack of time. We also found that small quantities of the single-use tourniquets will still be required as there are currently no reusable pediatric sizes available.

However, Greiner did confirm that they have got currently one in the works, so it may not be suitable for patients with fragile skin.

Next slide.

Overall, this project's shown that moving towards a reusable tourniquet, we can largely reduce costs and clinical waste and some CO2 to support sustainability in our trust. The trials identified that there were some preference to Daisy Grip, which can offer a more sustainable alternative to the current practice.

However, it's also highlighted some challenges like limited staff engagement due to time pressures and the preference for the single use, meaning if we want to embed this change, there will be a need for further training support in the future.

We also need to make sure that IPAC factors are considered when making this change to ensure staff patient safety. Currently, there's no decision to move towards the reusable tourniquets, and the services have decided for now that they'll stay using the single use. However, a future move to the reusable ones will still be considered as we believe it will be beneficial for the trust.

Right, next slide.

Our next steps.

So our next steps for now would be to promote the potential sustainable change to services and supporting anyone who would like to make that change by offering additional training information.

Although this project did not achieve the intended outcome which we wanted for now, we can still encourage the change by sharing the benefits of reusable tourniquets.

In the future, we have more of a structured approach by targeting services, certain teams, and allocating more time to participate in the trials.

We are now aware of the benefits of moving to a reusable, so we can make these expectations clear that we need to change to reusable to make it more sustainable and also consider IPAC factors and the safety of staff and patients.

Learn more about

Hyperlink

You must log in to save content

Click below to log in or create a new account

Login

You must log in to save content

Click below to log in or create a new account

Login